AstraZeneca said its third phase trial results showed its single-dose treatment was nearly 75% effective at preventing severe infection in babies throughout an RSV season.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
